STONKWHISPER
← Back to Intel
Insider ActivityDYN

Lucera Erick, Chief Financial Officer at Dyne Therapeutics, Inc., sold $107K of DYN

Updated Jun 11, 2026
Lucera Erick Chief Financial Officer
Dyne Therapeutics, Inc. · $DYN
$107K Total Value
5,727 Shares Traded
$18.64 Price / Share
125,373 Shares Owned After
2026-04-03 Filing Date

Transaction Details

InsiderLucera Erick
TitleChief Financial Officer
CompanyDyne Therapeutics, Inc.
TickerDYN
Transaction TypeSale
Transaction Date2026-04-01
Shares Traded5,727
Price Per Share$18.64
Total Value$107K
Filed Date2026-04-03
Accession Number0001193125-26-142137

Ownership Context

Shares Owned After Transaction125,373
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-142137

Other Insider Trades — DYN

Other Trades by Lucera Erick

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for DYN — Dyne Therapeutics, Inc. →

Track DYN insider activity in real time on The Wire →

Get alerts when Lucera Erick files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 11, 2026 at 07:22 UTC

Want real-time data? Access The Wire for live sentiment tracking.